rs150432347

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001848.3(COL6A1):​c.2642C>T​(p.Thr881Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00148 in 1,612,642 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T881T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00085 ( 0 hom., cov: 35)
Exomes 𝑓: 0.0015 ( 6 hom. )

Consequence

COL6A1
NM_001848.3 missense

Scores

3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.495

Publications

9 publications found
Variant links:
Genes affected
COL6A1 (HGNC:2211): (collagen type VI alpha 1 chain) The collagens are a superfamily of proteins that play a role in maintaining the integrity of various tissues. Collagens are extracellular matrix proteins and have a triple-helical domain as their common structural element. Collagen VI is a major structural component of microfibrils. The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI), and alpha3(VI) chains. The alpha2(VI) and alpha3(VI) chains are encoded by the COL6A2 and COL6A3 genes, respectively. The protein encoded by this gene is the alpha 1 subunit of type VI collagen (alpha1(VI) chain). Mutations in the genes that code for the collagen VI subunits result in the autosomal dominant disorder, Bethlem myopathy. [provided by RefSeq, Jul 2008]
COL6A1 Gene-Disease associations (from GenCC):
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bethlem myopathy 1A
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007489562).
BP6
Variant 21-46003568-C-T is Benign according to our data. Variant chr21-46003568-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 93863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000847 (129/152338) while in subpopulation NFE AF = 0.00123 (84/68022). AF 95% confidence interval is 0.00102. There are 0 homozygotes in GnomAd4. There are 59 alleles in the male GnomAd4 subpopulation. Median coverage is 35. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 6 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A1NM_001848.3 linkc.2642C>T p.Thr881Met missense_variant Exon 35 of 35 ENST00000361866.8 NP_001839.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A1ENST00000361866.8 linkc.2642C>T p.Thr881Met missense_variant Exon 35 of 35 1 NM_001848.3 ENSP00000355180.3

Frequencies

GnomAD3 genomes
AF:
0.000847
AC:
129
AN:
152220
Hom.:
0
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.000458
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00123
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000696
AC:
171
AN:
245540
AF XY:
0.000694
show subpopulations
Gnomad AFR exome
AF:
0.000450
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.000101
Gnomad EAS exome
AF:
0.0000560
Gnomad FIN exome
AF:
0.0000467
Gnomad NFE exome
AF:
0.00137
Gnomad OTH exome
AF:
0.000663
GnomAD4 exome
AF:
0.00154
AC:
2250
AN:
1460304
Hom.:
6
Cov.:
81
AF XY:
0.00150
AC XY:
1087
AN XY:
726510
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33468
American (AMR)
AF:
0.000291
AC:
13
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.0000766
AC:
2
AN:
26098
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39690
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86240
European-Finnish (FIN)
AF:
0.000134
AC:
7
AN:
52224
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5766
European-Non Finnish (NFE)
AF:
0.00191
AC:
2127
AN:
1111762
Other (OTH)
AF:
0.00142
AC:
86
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
160
321
481
642
802
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000847
AC:
129
AN:
152338
Hom.:
0
Cov.:
35
AF XY:
0.000792
AC XY:
59
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.000457
AC:
19
AN:
41588
American (AMR)
AF:
0.00105
AC:
16
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00123
AC:
84
AN:
68022
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00167
Hom.:
0
Bravo
AF:
0.000929
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00285
AC:
11
ESP6500AA
AF:
0.000455
AC:
2
ESP6500EA
AF:
0.00128
AC:
11
ExAC
AF:
0.000710
AC:
86
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00136
EpiControl
AF:
0.00130

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 01, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 26, 2016
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:3
Jul 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

COL6A1: BS2

Oct 17, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 24, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 30564623, 15689448)

Collagen 6-related myopathy Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Bethlem myopathy 1A Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
12
DANN
Benign
0.95
DEOGEN2
Benign
0.27
T;T
Eigen
Benign
-0.86
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.10
N
LIST_S2
Uncertain
0.87
D;D
M_CAP
Uncertain
0.15
D
MetaRNN
Benign
0.0075
T;T
MetaSVM
Benign
-0.76
T
MutationAssessor
Benign
0.69
N;.
PhyloP100
-0.49
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-0.67
N;.
REVEL
Benign
0.18
Sift
Benign
0.084
T;.
Sift4G
Benign
0.068
T;T
Vest4
0.12
ClinPred
0.018
T
GERP RS
-4.9
Varity_R
0.016
gMVP
0.33
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150432347; hg19: chr21-47423482; COSMIC: COSV100719992; COSMIC: COSV100719992; API